Erasca (ERAS) Assets Average (2021 - 2026)
Erasca (ERAS) reported Assets Average of $428.7 million for Q1 2026, down 11.95% on a YoY basis from $486.9 million in Q1 2025, and up 5.0% quarter-over-quarter from $408.3 million in Q4 2025.
Erasca (ERAS) Assets Average (2021 - 2026) Analysis & Trends
Erasca has reported Assets Average for 6 years, with the latest figure at $428.7 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 11.95% year-over-year to $428.7 million; the trailing twelve-month figure through Mar 2026 stood at $428.7 million (down 11.95% YoY), and the FY2025 full-year result was $449.3 million, changed 0.1% from the prior year.
- Assets Average for Q1 2026 stood at $428.7 million, up from $408.3 million in the prior quarter.
- The five-year high for Assets Average was $527.3 million in Q3 2024, with the low at $382.7 million in Q1 2024.
- Historically, Assets Average has averaged $455.7 million across 5 years, with a median of $454.1 million in 2023.
- Annual changes were most pronounced in 2024 — Assets Average dropped 22.1% — and 2025, when it gained 27.24%.
- Erasca's Assets Average stood at $480.7 million in 2022, then retreated by 15.25% to $407.4 million in 2023, then gained by 26.6% to $515.7 million in 2024, then retreated by 20.83% to $408.3 million in 2025, then increased by 5.0% to $428.7 million in 2026.
- The last three Assets Average figures came in at $428.7 million (Q1 2026), $408.3 million (Q4 2025), and $432.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | 428.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 428.69 Mn |
| Dec 31, 2025 | 408.28 Mn |
| Sep 30, 2025 | 432.89 Mn |
| Jun 30, 2025 | 458.32 Mn |
| Mar 31, 2025 | 486.89 Mn |
| Dec 31, 2024 | 515.71 Mn |
| Sep 30, 2024 | 527.32 Mn |
| Jun 30, 2024 | 447.88 Mn |
| Mar 31, 2024 | 382.66 Mn |
| Dec 31, 2023 | 407.35 Mn |
| Sep 30, 2023 | 430.03 Mn |
| Jun 30, 2023 | 454.10 Mn |
| Mar 31, 2023 | 491.23 Mn |
| Dec 31, 2022 | 480.67 Mn |
| Sep 30, 2022 | 445.63 Mn |
| Jun 30, 2022 | 460.15 Mn |
| Mar 31, 2022 | 488.44 Mn |
| Dec 31, 2021 | 511.68 Mn |
| Sep 30, 2021 | 366.17 Mn |